JAMES C. MULLEN - CEO, Director at Editas Medicine, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Issuer Symbol
EDIT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by JAMES C. MULLEN since 11 Feb 2025

Holdings reported by JAMES C. MULLEN for Editas Medicine, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 75,898 $827,076 $10.90 03 Jan 2022 Direct
Stock Option (right to buy) 170,989 14 Apr 2022 Direct Common Stock

Transactions reported by JAMES C. MULLEN for Editas Medicine, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.